GE HealthCare Technologies (GEHC) revenue breakdown
By segment, Imaging is the largest at 45% of fiscal 2025 revenue; PDx grew fastest, 9% a year over 4 years.
By product, Product is the largest at 66% of fiscal 2025 revenue, growing 5% a year over 4 years.
Revenue by segment
Fiscal years, as GE HealthCare Technologies reports them in its 10-K filings; fiscal 2025 total $20.6B.
| Segments | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Imaging | $9.4B | $8.4B | $8.9B | $8.9B | $9.2B | 45% |
| AVS | — | $5.0B | $5.1B | $5.1B | $5.4B | 26% |
| PCS | $2.9B | $2.9B | $3.1B | $3.1B | $3.1B | 15% |
| PDx | $2.0B | $2.0B | $2.3B | $2.5B | $2.9B | 14% |
| Ultrasound | $3.2B | — | — | — | — | — |
Revenue by product
Fiscal years, as GE HealthCare Technologies reports them in its 10-K filings; fiscal 2025 total $20.6B.
| Products | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Product | $11.2B | $12.0B | $13.1B | $13.1B | $13.7B | 66% |
| Service | $6.4B | $6.3B | $6.4B | $6.6B | $7.0B | 34% |
Revenue by region
Fiscal years, as GE HealthCare Technologies reports them in its 10-K filings; fiscal 2025 total $20.6B.
| Regions | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| All other countries | $8.0B | $8.2B | $8.8B | $8.9B | $9.4B | 46% |
| United States | $7.1B | $7.8B | $8.2B | $8.6B | $9.2B | 44% |
| China | $2.5B | $2.3B | $2.6B | $2.1B | $2.0B | 10% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GEHC.
Open GEHC in InvestinglyQuestions
Where does GE HealthCare Technologies make its money?
In fiscal 2025, by segment: Imaging $9.2B, AVS $5.4B, PCS $3.1B, PDx $2.9B.
From GE HealthCare Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.